Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin in Children with Recurrent or Persistent Acute Otitis Media
NCT00051753Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 2002
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, single-blind trial of levofloxacin in acute otitis media (AOM) (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Clinical response (cured versus not cured). Started Nov 2002; status: completed.
02
Drugs
levofloxacin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00051753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00051753.